HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Giulia Toni Selected Research

Vulvar Lichen Sclerosus

2/2024Topical Corticosteroid Phobia Among Women Affected With Vulvar Lichen Sclerosus: Results From a Cross-sectional Survey.
1/2024Searching for a "Window of Opportunity" in the Treatment of Vulvar Lichen Sclerosus: Evidence for Therapeutic Benefits of an Early Corticosteroid Treatment.
1/2023Does Clearance of Vulvar Lichen Sclerosus after a Corticosteroid Treatment Correspond to a Decrease in Disease-Related Burden? Results from a Cohort Study Using Pictorial Representation of Illness and Self-Measure and the Dermatology Life Quality Index.
1/2021Does longer duration of corticosteroid treatment improve clearance in vulvar lichen sclerosus? Results from a single centre, comparative, open label study.
11/2018Combining topical tretinoin with mometasone furoate in the treatment of vulvar lichen sclerosus: Results of dermoscopic assessment.
5/2018Mometasone furoate in the treatment of vulvar lichen sclerosus: could its formulation influence efficacy, tolerability and adherence to treatment?
9/2017Combined therapy in vulvar lichen sclerosus: does topical tretinoin improve the efficacy of mometasone furoate?
9/2016Clinical and dermoscopic changes of vulvar lichen sclerosus after topical corticosteroid treatment.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Giulia Toni Research Topics

Disease

8Vulvar Lichen Sclerosus
02/2024 - 09/2016
2Actinic Keratosis
04/2024 - 11/2023
2Allergic Contact Dermatitis
01/2020 - 11/2019
2Acne Vulgaris
01/2017 - 01/2013
1Phobic Disorders (Phobia)
02/2024
1Skin Diseases (Skin Disease)
02/2024
1Ectropion
11/2023
1Hypersensitivity (Allergy)
12/2019
1Dermatitis
11/2019
1Contact Dermatitis (Eczema, Contact)
07/2019
1Neurodermatitis (Lichen Simplex Chronicus)
08/2015
1Neoplasms (Cancer)
11/2011

Drug/Important Bio-Agent (IBA)

7Adrenal Cortex Hormones (Corticosteroids)IBA
02/2024 - 09/2016
4Ointments (Pastes)IBA
04/2024 - 09/2016
4Mometasone Furoate (Nasonex)FDA LinkGeneric
11/2018 - 09/2016
3Isotretinoin (Accutane)FDA LinkGeneric
01/2017 - 11/2011
2Irritants (Vesicants)IBA
12/2019 - 07/2019
2Tretinoin (Retinoic Acid)FDA LinkGeneric
11/2018 - 09/2017
2RetinoidsIBA
09/2017 - 01/2013
1tirbanibulinIBA
04/2024
1Clotrimazole (Lotrimin)FDA LinkGeneric
01/2020
1lavender oilIBA
11/2019
1Volatile Oils (Essential Oils)IBA
11/2019
1Gentamicins (Gentamicin)FDA LinkGeneric
11/2019
1EmollientsIBA
11/2018
1Vitamin A (Retinol)FDA LinkGeneric
01/2017
1SilkFDA Link
08/2015
1Benzoyl PeroxideFDA LinkGeneric
01/2013
1Adapalene (Differin)FDA LinkGeneric
01/2013
1Minocycline (Cyclops)FDA LinkGeneric
11/2011

Therapy/Procedure

3Therapeutics
09/2017 - 01/2013
1Photochemotherapy (Photodynamic Therapy)
11/2023
1Aromatherapy
11/2019
1Aftercare (After-Treatment)
01/2013